Skip to main content
Clinical Trials/JPRN-UMIN000033335
JPRN-UMIN000033335
Not Yet Recruiting
N/A

esional evaluation of high-risk patients with neoatherosclerosis treated with rosuvastatin and eicosapentaenoic acid using OCT and NIRS IVUS - LINK IT two

Kobe University0 sites75 target enrollmentSeptember 1, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
ischemic heart disease
Sponsor
Kobe University
Enrollment
75
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 1, 2018
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1 Patients taking omega 3 fatty acid before randomization 2 Patients allergic to rosuvastatin or eicosapentaenoic acid 3 Patients with a history of hemorrhagic stroke 4 Patients taking anti cancer agent 5 Patients undergoing LDL apheresis 6 Patients with severe liver disease or severe kidney disease 7 Patients who conflict with any of the warnings or contraindications listed in the domestic package insert of rosuvastatin 8 Patients who conflict with any of the warnings or contraindications listed in the domestic package insert of eicosapentaenoic acid 9 Patients perfomed PCI with restenosis of target lesion 10 Pregnant women or patients with possibilty of Pregnancy or nursing woman

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
N/A
Evaluation and analysis of patients presenting neurodegenerative dementia or parkinsonism with [18F]THK-5351 positron emission tomographymild cognitive impairment(MCI),Alzheimer-type dementia(AD), frontotemporal dementia(FTD), corticobasal degeneration(CBD),progressive supranuclear palsy(PSP),Parkinson&#39s disease with dementia(PDD),dementia with Lewy bodies(DLB),Parkinson&#39s disease(PD),multiple system atrophy(MSA),healthy control(HC)
JPRN-UMIN000018496agoya University Department of Neurology220
Recruiting
N/A
Evaluation and analysis of patients presenting neurodegenerative dementia with [11C]PiB positron emission tomographymild cognitive impairment(MCI),Alzheimer-type dementia(AD), Parkinson&#39s disease with dementia(PDD),dementia with Lewy bodies(DLB),Parkinson&#39s disease(PD),multiple system atrophy(MSA),healthy control(HC)
JPRN-UMIN000019363agoya University Department of Neurology160
Recruiting
N/A
Brain Pulse Monitoring Study in patients with or at risk of developing stroke to provide earlier detection of strokeStrokeNeurological - Other neurological disordersStroke - HaemorrhagicStroke - Ischaemic
ACTRN12622001320741Cyban Pty Ltd100
Recruiting
N/A
Patient reported outcomes in high risk and advanced melanoma patients
NL-OMON51119Antoni van Leeuwenhoek Ziekenhuis300
Recruiting
N/A
Patient reported outcomes in high risk and advanced melanoma patientsHigh-risk (resectable stage III) or advanced (stage IV and unresectable stage III) melanoma
NL-OMON20229one, investigator initiated300